VST #hotstock has closed the acquisition of Authority National Supply (ANS). ANS was their sixth transaction to date, and has generated $22.8 million in sales.
Innovest Global, Inc. $IVST #hotstock is a diversified Public Holding company that is already a ten-bagger this year with much more on the way based on fundamentals AND technicals!
IVST #hotstock has closed the acquisition of Authority National Supply (ANS) is closed. ANS was our sixth transaction to date, and has generated $22.8 million in sales through the first three quarters of 2018. IVST now has approximately 55 employees and $34 million in annual run-rate revenue.
Innovest Global Signed an LOI to Acquire Midwest Curtainwalls, a $12 Million Revenue and Profitable Business. Midwest is a company that will add to our Construction and Building Materials efforts. They generate $10-$12 million in annual revenue from specialty commercial construction contracts, with projections of $2.4 million in profit from current contract
Innovest Global, Inc. (OTC Markets: IVST #hotstock) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire niche, high-growth businesses that are capable of generating significant annual revenue. Planned subsidiaries operate across telehealth, biotech, building materials, commercial energy, business-to-business distribution, national call center and auto sales.
Based out of Cleveland, Ohio, IVST #hotstock is easily one of the better fundamental companies trading on the OTC marketplace. Innovest Global, Inc. is already up 10-fold in 2018, after starting off 2018 around $0.02 before shooting to an all-time high of $0.55 recently. IVST continues to hold onto the nice gains thus far holding strong in the .40-.45 range ready for the next leg up! Based upon the company’s strong fundamental AND technical picture, Innovest Global, Inc. could easily eclipse its all-time high by the end of 2018.
What a stock structure IVST #hotstock has investors! The company has an amazing unchanged free-trading float of 11,796,710 common shares with NO convertible debts, no warrants or options outstanding, and employs 45.
IVST #hotstock owns 20% of StemVax Therapeutics which is the first company in its Biotech Division. StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. Lead by world-renowned neuroscientist, Dr. Dwain Morris-Irvin, the Biotech & Health Sciences Division is currently focused on commercializing StemVax’s cancer vaccination therapy technology. The cancer vaccination therapy technology was just recently awarded a U.S. patent!